Jilin Aodong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Jilin Aodong Pharmaceutical Group Co Ltd free cash flow generation index. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Free Cash Flow Generation Index of 0.77x as of September 2025. Free cash flow of CN¥86.32 Million represents 1% of operating cash flow (CN¥112.12 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Free cash flow generation index of Jilin Aodong Pharmaceutical Group Co Ltd from 1999 to 2025. Historical FCF Generation Index trend for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. See 000623 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Jilin Aodong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (1999–2025)
Jilin Aodong Pharmaceutical Group Co Ltd free cash flow generation index by year from 1999 to 2025. Year-by-year Free Cash Flow Generation Index for Jilin Aodong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥143.81 Million | CN¥272.26 Million | CN¥128.45 Million | ▲ +114.6% |
| 2024 | -3.61x | CN¥-214.50 Million | CN¥59.48 Million | CN¥273.98 Million | ▲ +30.2% |
| 2023 | -5.16x | CN¥-351.46 Million | CN¥68.06 Million | CN¥419.52 Million | ▼ -1531.6% |
| 2022 | 0.36x | CN¥152.89 Million | CN¥423.86 Million | CN¥270.97 Million | ▲ +915.0% |
| 2021 | 0.04x | CN¥11.54 Million | CN¥324.85 Million | CN¥313.30 Million | ▼ -91.5% |
| 2020 | 0.42x | CN¥163.02 Million | CN¥390.41 Million | CN¥227.38 Million | ▲ +0.9% |
| 2019 | 0.41x | CN¥157.06 Million | CN¥379.46 Million | CN¥222.40 Million | ▲ +40.6% |
| 2018 | 0.29x | CN¥102.33 Million | CN¥347.64 Million | CN¥245.30 Million | ▼ -56.2% |
| 2017 | 0.67x | CN¥172.56 Million | CN¥256.49 Million | CN¥83.93 Million | ▲ +27.8% |
| 2016 | 0.53x | CN¥175.79 Million | CN¥333.81 Million | CN¥158.03 Million | ▲ +279.0% |
| 2015 | 0.14x | CN¥53.92 Million | CN¥388.03 Million | CN¥334.11 Million | ▲ +135.5% |
| 2014 | -0.39x | CN¥-113.18 Million | CN¥288.83 Million | CN¥402.01 Million | ▲ +26.8% |
| 2013 | -0.54x | CN¥-107.79 Million | CN¥201.22 Million | CN¥309.01 Million | ▼ -168.3% |
| 2012 | -0.20x | CN¥-54.40 Million | CN¥272.40 Million | CN¥326.80 Million | ▲ +93.8% |
| 2011 | -3.23x | CN¥-349.42 Million | CN¥108.30 Million | CN¥457.72 Million | ▼ -2628.9% |
| 2010 | 0.13x | CN¥22.23 Million | CN¥174.22 Million | CN¥152.00 Million | ▼ -84.6% |
| 2009 | 0.83x | CN¥176.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▼ -4.3% |
| 2008 | 0.87x | CN¥203.51 Million | CN¥235.03 Million | CN¥31.52 Million | ▼ -3.6% |
| 2007 | 0.90x | CN¥345.45 Million | CN¥384.69 Million | CN¥39.24 Million | ▲ +28.7% |
| 2006 | 0.70x | CN¥131.12 Million | CN¥187.99 Million | CN¥56.87 Million | ▲ +18.0% |
| 2005 | 0.59x | CN¥80.57 Million | CN¥136.26 Million | CN¥55.68 Million | ▼ -25.0% |
| 2004 | 0.79x | CN¥172.35 Million | CN¥218.53 Million | CN¥46.19 Million | ▲ +108.8% |
| 2003 | 0.38x | CN¥55.76 Million | CN¥147.65 Million | CN¥91.89 Million | ▲ +176.4% |
| 2001 | -0.49x | CN¥-68.61 Million | CN¥138.76 Million | CN¥207.37 Million | ▲ +56.1% |
| 2000 | -1.13x | CN¥-86.86 Million | CN¥77.04 Million | CN¥163.90 Million | ▼ -413.2% |
| 1999 | 0.36x | CN¥39.66 Million | CN¥110.18 Million | CN¥70.52 Million | — |